| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.09 |